Left atrial myxoma is the most prevalent primary cardiac tumor, known for its high risk of systemic embolization. Although surgical excision remains the standard treatment, options are limited for high-risk patients. This case report introduces a novel approach using transcatheter electrosurgery to address a left atrial myxoma via a transseptal approach in a patient ineligible for conventional surgery due to the heightened risk of intracranial hemorrhage associated with cerebral amyloid angiopathy. Despite encountering technical challenges, this innovative procedure represents a pioneering application of transcatheter surgery for managing left heart tumors.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11733555 | PMC |
http://dx.doi.org/10.1016/j.jaccas.2024.102718 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!